Tadej Avĉin

Prof. Dr. Tadej Avĉin

Ljubljana University Medical Centre | UMC · Unit of Allergy, Rheumatology and Clinical Immunology, Ljubljana, Slovenia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2023 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
MBMedha Barbhaiya
Medha Barbhaiya
SZStephane Zuily
Stephane Zuily
RNRay Naden
Ray Naden
AHAlison Hendry
Alison Hendry
FMFlorian Manneville
Florian Manneville
TCThe Acr/Eular Aps Classification Criteria Collaborators
The Acr/Eular Aps Classification Criteria Collaborators

1 November 2008 in Pediatrics
Verified
Journal Article
Closed access
PDF file
Tadej AvĉinTadej Avĉin
Tadej Avĉin
RCRolando Cimaz
Rolando Cimaz
ESEarl D. Silverman
Earl D. Silverman
RCRicard Cervera
Ricard Cervera
MGMarco Gattorno
Marco Gattorno
PMPier Luigi Meroni
Pier Luigi Meroni
OBJECTIVES. The purpose of this study was to obtain data on the association of antiphospholipid antibodies with clinical manifestations in childhood and to enable future studies to determine the impact of treatment and long-term outcome of pediatric antiphospholipid syndrome. PATIENTS AND METHODS. A European registry extended internationally of pediatric patients with antiphospholipid syndrome was established as a collaborative project of the European Antiphospholipid Antibodies Forum and Lupus Working Group of the Pediatric Rheumatology European Society. To be eligible for enrollment the patient must meet the preliminary criteria for the classification of pediatric antiphospholipid syndrome and the onset of antiphospholipid syndrome must have occurred before the patient9s 18th birthday. RESULTS. As of December 1, 2007, there were 121 confirmed antiphospholipid syndrome cases registered from 14 countries. Fifty-six patients were male, and 65 were female, with a mean age at the onset of antiphospholipid syndrome of 10.7 years. Sixty (49.5%) patients had underlying autoimmune disease. Venous thrombosis occurred in 72 (60%), arterial thrombosis in 39 (32%), small-vessel thrombosis in 7 (6%), and mixed arterial and venous thrombosis in 3 (2%). Associated nonthrombotic clinical manifestations included hematologic manifestations (38%), skin disorders (18%), and nonthrombotic neurologic manifestations (16%). Laboratory investigations revealed positive anticardiolipin antibodies in 81% of the patients, anti-β2-glycoprotein I antibodies in 67%, and lupus anticoagulant in 72%. Comparisons between different subgroups revealed that patients with primary antiphospholipid syndrome were younger and had a higher frequency of arterial thrombotic events, whereas patients with antiphospholipid syndrome associated with underlying autoimmune disease were older and had a higher frequency of venous thrombotic events associated with hematologic and skin manifestations. CONCLUSIONS. Clinical and laboratory characterization of patients with pediatric antiphospholipid syndrome implies some important differences between antiphospholipid syndrome in pediatric and adult populations. Comparisons between children with primary antiphospholipid syndrome and antiphospholipid syndrome associated with autoimmune disease have revealed certain differences that suggest 2 distinct subgroups.

29 October 2021 in Science Immunology
Verified
Journal Article
Closed access
BKBaerbel Keller
Baerbel Keller
VSValentina Strohmeier
Valentina Strohmeier
IHIna Harder
Ina Harder
SUSusanne Unger
Susanne Unger
KPKathryn J. Payne
Kathryn J. Payne
KWKlaus Warnatz
Klaus Warnatz
T cell–derived IFNγ and CD40L/IL-21R signals are crucial for the differentiation of human T-bet high CD21 low B cells.

23 May 2016 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
AGAleš Goropevšek
Aleš Goropevšek
MHMarija Holcar
Marija Holcar
Tadej AvĉinTadej Avĉin
Tadej Avĉin

26 May 2014 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
MBMarek Bohm
Marek Bohm
MFMaria Isabel Gonzalez Fernandez
Maria Isabel Gonzalez Fernandez
SOSeza Ozen
Seza Ozen
APAngela Pistorio
Angela Pistorio
PDPavla Dolezalova
Pavla Dolezalova
T(the Paediatric Rheumatology International Trials Organisation (PRINTO)
the Paediatric Rheumatology International Trials Organisation (PRINTO)
Background: Granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis (WG), belongs to the group of ANCA-associated necrotizing vasculitides. This study describes the clinical picture of the disease in a large cohort of GPA paediatric patients. Children with age at diagnosis ≤ 18 years, fulfilling the EULAR/PRINTO/PRES GPA/WG classification criteria were extracted from the PRINTO vasculitis database. The clinical signs/symptoms and laboratory features were analysed before or at the time of diagnosis and at least 3 months thereafter and compared with other paediatric and adult case series (>50 patients) derived from the literature. Findings: The 56 children with GPA/WG were predominantly females (68%) and Caucasians (82%) with a median age at disease onset of 11.7 years, and a median delay in diagnosis of 4.2 months. The most frequent organ systems involved before/at the time of diagnosis were ears, nose, throat (91%), constitutional (malaise, fever, weight loss) (89%), respiratory (79%), mucosa and skin (64%), musculoskeletal (59%), and eye (35%), 67% were ANCA-PR3 positive, while haematuria/proteinuria was present in > 50% of the children. In adult series, the frequency of female involvement ranged from 29% to 50% with lower frequencies of constitutional (fever, weight loss), ears, nose, throat (oral/nasal ulceration, otitis/aural discharge), respiratory (tracheal/endobronchial stenosis/obstruction), laboratory involvement and higher frequency of conductive hearing loss than in this paediatric series. Conclusions: Paediatric patients compared to adults with GPA/WG have similar pattern of clinical manifestations but different frequencies of organ involvement.

20 June 2007 in Current Rheumatology Reports
Verified
Journal Article
Closed access
PDF file
Tadej AvĉinTadej Avĉin
Tadej Avĉin
NTNataša Toplak
Nataša Toplak